Kovack Advisors’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Sell
175,232
-99
-0.1% -$892 0.09% 229
2025
Q4
$1.57M Buy
175,331
+48
+0% +$454 0.07% 254
2025
Q3
$1.67M Buy
175,283
+28,495
+19% +$286K 0.16% 126
2025
Q2
$1.29M Buy
146,788
+41
+0% +$333 0.13% 158
2025
Q1
$1.1M Buy
146,747
+589
+0.4% +$4.68K 0.12% 162
2024
Q4
$1.22M Sell
146,158
-2,644
-2% -$22.6K 0.12% 145
2024
Q3
$1.03M Sell
148,802
-730
-0.5% -$4.96K 0.11% 158
2024
Q2
$733K Buy
149,532
+7,686
+5% +$36.4K 0.08% 223
2024
Q1
$823K Buy
141,846
+445
+0.3% +$2.73K 0.1% 169
2023
Q4
$926K Buy
141,401
+17,292
+14% +$80.9K 0.11% 180
2023
Q3
$598K Buy
124,109
+2,791
+2% +$13.9K 0.08% 223
2023
Q2
$619K Sell
121,318
-1,504
-1% -$8.11K 0.08% 248
2023
Q1
$676K Buy
122,822
+15,878
+15% +$84K 0.09% 222
2022
Q4
$491K Sell
106,944
-2,110
-2% -$10.7K 0.07% 285
2022
Q3
$680K Buy
109,054
+22,964
+27% +$130K 0.1% 218
2022
Q2
$384K Sell
86,090
-12,232
-12% -$55.8K 0.05% 384
2022
Q1
$494K Buy
98,322
+10,025
+11% +$63.8K 0.05% 390
2021
Q4
$769K Buy
88,297
+20,037
+29% +$179K 0.07% 285
2021
Q3
$637K Buy
68,260
+7,881
+13% +$79.4K 0.07% 315
2021
Q2
$774K Buy
+60,379
New +$649K 0.09% 250

Other funds holding ZVRA